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A B S T R A C T
This is the protocol for a review and there is no abstract. The objectives are as follows:
To determine the effects of home-based therapy programmes for upper limb recovery in patients with upper limb impairment following
stroke, compared with:
(1) placebo or no intervention;
(2) usual care.
Question to be answered
Are home-based therapy programmes effective at improving upper limb recovery in patients with upper limb impairment after stroke?
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B A C K G R O U N D
Stroke is a major cause of death and disability throughout the
world, consuming significant resources (Isard 1992). It is therefore
imperative that stroke services are effective and efficient. Prob-
lems affecting the upper limb following stroke are often persistent
and disabling, with only 20% (Parker 1986) to 56% (Nakayama
1994) of patients regaining useful upper limb function after three
months. In addition, motor impairment has been shown to be the
most influential factor in determining well-being one year after
stroke (Wyller 1998). Improving upper limb function is therefore
often a core element of rehabilitation after stroke in order to max-
imise patient outcomes and reduce disability (Langhorne 2003).
Increasingly the trend within health service delivery (including
stroke care) is toward decreasing lengths of stay for inpatient care
and moving care into the community, which has lead to the devel-
opment of home-based stroke services (ESDT 2005). A Cochrane
review of therapy-based rehabilitation services for stroke patients
at home (OPT2006) found such services reduce the odds of a poor
outcome in ability to perform activities of daily living (ADL) and
have a beneficial effect on a patient’s ability to perform personal
ADL and extended ADL compared to conventional or no care.
This review specifically investigated therapy service interventions
primarily aiming to improve task-orientated behaviour (not upper
limb interventions or outcomes) and was based on a review of het-
erogeneous interventions. This planned review intends to exclu-
sively investigate the effects of home-based therapy programmes
targeted at upper limb recovery.
The effectiveness of specific upper limb interventions has been,
or is in the process of being reviewed within other Cochrane sys-
tematic reviews: EMG biofeedback (Woodford 2004), electros-
timulation (Pomeroy 2006), mental practice (Stevenson 2006),
constraint-induced movement therapy (Sirtori 2003), repetitive
task training (French 2006) and simultaneous bilateral training
(Coupar 2007). This planned review does not intend to replicate
or overlap with these other reviews, as the focus will be on pro-
grammes of interventions completed at home rather than on a
specific intervention.
With an increased focus on home-based stroke services and the
undertaking of programmes of interventions, targeted at upper
limb recovery within clinical practice, a systematic review of home-
based therapy programmes for individuals with upper limb im-
pairment following stroke is deemed appropriate.
O B J E C T I V E S
To determine the effects of home-based therapy programmes for
upper limb recovery in patients with upper limb impairment fol-
lowing stroke, compared with:
(1) placebo or no intervention;
(2) usual care.
Question to be answered
Are home-based therapy programmes effective at improving upper
limb recovery in patients with upper limb impairment after stroke?
M E T H O D S
Criteria for considering studies for this review
Types of studies
Wewill include controlled trials if participants have been randomly
assigned (that is, each participant has an equal chance of being
in either group). Random allocation could be completed by hav-
ing computer-generated random numbers or using sequentially-
numbered opaque sealed envelopes. We will include only the first
phase of cross-over studies to exclude any carry-over or learning
effects.
We will include trials with or without blinding of participants,
treating therapist(s) and assessor(s). Wewill document and present
information on these variables within the review. Studies must in-
clude an intervention group of a home-based therapy programme
and a comparison group of placebo or usual care (’conventional’
or ’traditional’). We will also include studies that include a home-
based therapy programme in addition to usual care compared with
usual care alone. Usual care will be determined by the original trial
authors when it is considered to be a normal or usual component
of stroke rehabilitation. We will document the description of the
usual care and we will seek additional information from study au-
thors if necessary.
We will only include studies if the therapist has visited the patient
in their own home (at least once) to prescribe treatment.
Types of participants
We will include participants with a clinical diagnosis of stroke -
’a syndrome of rapidly developing symptoms and signs of focal,
and at times, global, loss of cerebral function lasting more than 24
hours or leading to death, with no apparent cause other than that
of vascular origin’ (WHO 1989) - regardless of time since onset,
initial upper limb impairment, ability to follow instructions, co-
morbidities, previous strokes or location of stroke. We will collect
and document data on these variables, and will then use this data
to carry out appropriate subgroup analysis. We will include studies
that also recruited participants with other neurological disorders if
more than 50% of participants are stroke patients; we will contact
study authors for relevant data if required. We will include only
participants living in their own homes (that is, at their permanent
address). This may include care homes and other forms of sup-
ported or sheltered accommodation.
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Types of interventions
Studies must investigate a home-based therapy programme, tar-
geted at upper limb recovery following stroke. For the purposes
of this review home-based therapy programmes will be defined as
those including the following elements:
(1) carried out in the patient’s home (that is, at their permanent
address; this may include care homes and other forms of supported
or sheltered accommodation);
(2) prescribed by healthcare professionals or individuals under the
supervision of healthcare professionals;
(3) includingmore than one specific intervention targeted at upper
limb recovery.
The rationale for including only these trials with more than one
specific intervention is to avoid studies of single upper limb inter-
ventions. The focus of this review is a ’programme’ of therapy. A
programme of therapy will always include several different treat-
ment interventions. The effectiveness of single interventions for
the upper limb are assessed in other reviews. Excluding trials that
assess only one specific intervention will effectively limit this re-
view to trials of ’programmes’, reduce or avoid overlap with other
reviews, and reflect clinical reality. We will, however, record trials
that investigate one specific intervention administered within pa-
tients’ own homes.
We will include studies of complex packages of rehabilitation if
the administered package includes interventions targeted at upper
limb recovery and includes the three elements outlined above. If
this information is not clear from the study then we will attempt
to contact the trial authors for clarification.
Any duration or intensity of programme will be included and
subgroup analysis completed as appropriate.Wewill document the
professional background, training and experience of the person(s)
delivering the intervention andwewill seek additional information
from the study author(s) if necessary.
Types of outcome measures
The primary or initial aim of many upper limb interventions is
often to improve functional movement and reduce impairment.
However, it is debatable how meaningful these aspects are to indi-
vidual patients. Themost important goal for patients is arguably to
improve their ability to participate in and independently achieve
activities of daily living. Additionally, this is the over-arching aim
of all rehabilitation interventions. Since the key motivation of this
review is to improve patient care and ensure meaningful outcomes,
performance in activities of daily living was chosen as a primary
outcome of interest.
Primary outcomes
(1) Performance in activities of daily living (including feeding,
toileting, dressing, bathing, simple mobility and transfers). Mea-
sures will be global measures of activities of daily living such as the
Barthel Index. It must be acknowledged that many of the existing
measures of performance in activities of daily living have limita-
tions relating to sensitivity and specificity for measuring a change
in upper limb function, and therefore a second primary outcome
specific to upper limb function is proposed.
(2) Functional movement (such as measures of active movement,
co-ordination, dexterity, manipulation, grasp/grip/pinch). Mea-
sures are likely to include the Action Research ArmTest, the River-
mead Motor Assessment (RMA), Motricity Index and the 10 hole
peg test.
Secondary outcomes
(1) Performance in extended activities of daily living (including
shopping, household tasks). Measures are likely to include the
Nottingham Extended Activities of Daily Living.
(2) Motor impairment (measures of general upper limb impair-
ment, muscle strength, muscle tone). Measures are likely to in-
cludemuscle testing, the Ashworth scale, the Fugl-Meyer scale and
upper limb kinematics.
Additional outcomes
(1) Adverse events (such as death, pain).
Outcomes will be completed at the end of intervention period and
at the end of scheduled follow up.
Search methods for identification of studies
See: ’Specialized register’ section in Cochrane Stroke Group
We will search the Cochrane Stroke Group Trials Register. In ad-
dition, we will search the Cochrane Central Register of Controlled
Trials (CENTRAL) (The Cochrane Library, latest issue), MED-
LINE (1950 to present), EMBASE (1980 to present) CINAHL
(1982 to present) and AMED (1985 to present) (Appendix 1).
We will also search the following occupational therapy and phys-
iotherapy databases:
• OTseeker (http://www.otseeker.com/);
• OT Search (http://www.aota.org/otsearch/index.asp);
• Physiotherapy Evidence database (PEDro, http://




We will develop search strategies in consultation with the
Cochrane Stroke Group’s Trials Search Co-ordinator to avoid du-
plication of effort.
We will identify and handsearch relevant journals and confer-
ence proceedings that have not been searched on behalf of The
CochraneCollaboration. In an effort to identify further published,
unpublished and ongoing trials we will:
(1) check reference lists of all relevant articles;
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(2) search ongoing trials and research registers including Clini-
calTrials.gov (http://www.clinicaltrials.gov/) and the National Re-
search Register (http://www.nrr.nhs.uk/search.htm);
(3) contact investigators known to be involved in research in this
area;
(4) search Science Citation Index using the cited reference search;
(5) search dissertation abstracts (http://wwwlib.umi.com/disser-
tations/search).
Data collection and analysis
Identification of relevant trials
One review author (FC) will read the titles of the identified refer-
ences and eliminate any obviously irrelevant studies. We will then
obtain the abstracts for the remaining studies and, based on the
inclusion criteria (types of studies, types of participants, aims of
interventions, outcome measures), two review authors (FC and
PvV or CS) will independently rank these as ’possibly relevant’
or ’definitely irrelevant’. If both review authors identify a trial as
’definitely irrelevant’ we will exclude this trial at this point. We will
retrieve the full text of trials categorised as ’possibly relevant’, re-
view them and classify them as ’include’, ’exclude’ or ’unsure’. We
will exclude trials classified as ’exclude’ by both review authors. If
there is disagreement between review authors, or a decision cannot
be reached, we will seek consensus through discussion, including
a third review author if necessary.
Documentation of methodological quality
Two review authors will independently assess the methodological
quality of the studies using a standard critical appraisal assessment
form. Assessment of the quality of studies will focus on potential
areas of bias within the studies as this has been shown to affect the
estimation of effectiveness of interventions. We will consider and
document the following:
(1) generation of randomisation sequence;
(2) allocation concealment;
(3) baseline comparison between groups;
(4) blinding of outcome assessor;
(5) blinding of participants;
(6) blinding of therapists;
(7) intention-to-treat analysis possibility;
(8) number of patients lost to follow up;
(9) possibility to contamination or co-intervention by therapists
providing intervention;
(10) other potential confounders.
Any disagreements between the two review authors will be resolved
through discussion, including a third review author if necessary.
We will contact trial authors for clarification and to obtain missing
data if required.
Data extraction
Two review authors will independently extract data from the stud-
ies using a standard data extraction form. We will attempt to ob-
tain any missing data by contacting trial authors. If possible we
will document:
(1) participant details (including age, gender, place of residence,
type of stroke, time since stroke, initial upper limb impairment,
co-morbid conditions, premorbid disability);
(2) the inclusion and exclusion criteria;
(3) the duration/intensity/frequency of intervention;
(4) a brief description of the home-based therapy programme (in-
cluding details of administered therapy programme (including if
part of early supported discharge or standard discharge protocol),
involvement of treating therapist and qualifications and experi-
ence of treating therapist(s));
(5) the comparison intervention;
(6) the outcomes.
Comparisons to be made
(1) Home-based therapy programme versus placebo or no inter-
vention
(2) Home-based therapy programme versus usual care
(3) Home-based therapy programme plus usual care versus usual
care
We will document and report information relating to ’usual care’
including any treatment provided to participants in this group
and the amount/intensity of any such treatment. We will contact
authors for more information if required.
Data analysis
For each comparison the study results for performance in activi-
ties of daily living, measures of upper limb functional movement,
measures of motor impairment, and adverse effects will be used if
documented. We will use The Cochrane Collaboration’s Review
Manager software, RevMan 4.2, for all analyses. If possible, we
will use intention-to treat analyses.
We will analyse dichotomous data using the odds ratio and 95%
confidence interval employing a fixed-effect model with explo-
ration of sources of heterogeneity. Activities of daily living data,
such as the Barthel Index, will be treated as continuous outcomes
and mean and standard deviation data will be recorded. We will
analyse continuous outcomes as the standardised mean difference
and 95% confidence intervals. Results will be subjected to a ran-
dom-effects meta-analysis to take account of statistical hetero-
geneity. Heterogeneity will be determined using the I-squared (I
2)statistic (I2 greater than 50% is considered substantial hetero-
geneity). If heterogeneity is found to be present, we will explore
and present possible causes.
We will undertake the following subgroup analyses if there is suf-
ficient data on the primary outcomes:
(1) initial upper limb severity;
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(2) place of residence (own home, residential or nursing care);
(3) self practice versus no self practice;
(4) duration, intensity and frequency of intervention (interven-
tion less than four weeks and intervention more than four weeks,
intervention less than three times a week and intervention more
than three times a week).
Subgroup analysis will be completed using the Deeks method (
Deeks 2001).
Sensitivity analysis based on methodological quality of studies will
also be completed (clarity of randomisation procedure and allo-
cation concealment, blinding of outcome assessor, intention-to-
treat analysis, type of study).
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A P P E N D I C E S
Appendix 1. MEDLINE search strategy
We will use the following search strategy, using a combination of controlled vocabulary (MeSH) and free text terms, for MEDLINE
and will modify it to suit other databases.
1. cerebrovascular disorders/ or exp basal ganglia cerebrovascular disease/ or exp brain ischemia/ or exp carotid artery diseases/ or
cerebrovascular accident/ or exp brain infarction/ or exp cerebrovascular trauma/ or exp hypoxia-ischemia, brain/ or exp intracranial
arterial diseases/ or intracranial arteriovenous malformations/ or exp “Intracranial Embolism and Thrombosis”/ or exp intracranial
hemorrhages/ or vasospasm, intracranial/ or vertebral artery dissection/
2. (stroke or poststroke or post-stroke or cerebrovasc$ or brain vasc$ or cerebral vasc$ or cva$ or apoplex$ or SAH).tw.
3. ((brain$ or cerebr$ or cerebell$ or intracran$ or intracerebral) adj5 (isch?emi$ or infarct$ or thrombo$ or emboli$ or occlus$)).tw.
4. ((brain$ or cerebr$ or cerebell$ or intracerebral or intracranial or subarachnoid) adj5 (haemorrhage$ or hemorrhage$ or haematoma$
or hematoma$ or bleed$)).tw.
5. hemiplegia/ or exp paresis/
6. (hemipleg$ or hemipar$ or paresis or paretic).tw.
7. 1 or 2 or 3 or 4 or 5 or 6
8. exp Upper Extremity/
9. (upper adj3 (limb$ or extremity)).tw.
10. (arm or shoulder or elbow or forearm or hand or wrist or finger or fingers).tw.
11. 8 or 9 or 10
12. 7 and 11
13. community health services/ or community health nursing/ or community networks/ or home care services/ or home care services,
hospital-based/ or home nursing/
14. homebound persons/ or home health aides/ or home care agencies/ or house calls/ or primary health care/ or aftercare/
15. residential facilities/ or assisted living facilities/ or group homes/ or halfway houses/ or homes for the aged/ or exp nursing homes/
16. housing for the elderly/ or long-term care/ or institutionalization/
17. (home$ or house$ or domicile or domiciliary or community or institution$ or outreach or sheltered accomm$).tw.
18. ((resident$ or long-term) adj5 (care or facilit$)).tw.
19. or/13-18
20. 12 and 19
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